Sara Rosenbaum, J.D., is the Harold and Jane Hirsh Professor and founding Chair of the Department of Health Policy, George Washington University School of Public Health and Health Services, a unique center of learning, scholarship, and public service focusing on all aspects of health policy.
Professor Rosenbaum has devoted her career to issues of health law and policy affecting low income, minority, and medically underserved populations. Between 1993 and 1994, Professor Rosenbaum worked for President Clinton, directing the legislative drafting of the Health Security Act and developing the Vaccines for Children program. Professor Rosenbaum also served on the Presidential Transition Team for President-Elect Obama.
A graduate of Wesleyan University and Boston University School of Law, Professor Rosenbaum has authored a leading health law textbook as well as more than 350 articles and studies focusing on all phases of health law and health care for medically underserved populations. A holder of numerous awards for her scholarship and service, Professor Rosenbaum is the recipient of the Richard and Barbara Hansen National Health Leadership Award (University of Iowa), a Robert Wood Johnson Foundation Investigator Award in Health Policy Research, and the Oscar and Shoshanna Trachtenberg Award for Scholarship, George Washington University’s highest award for scholarship.
Professor Rosenbaum is a member of CDC’s Advisory Committee on Immunization Practice (ACIP) and Director’s Advisory Committee. She also serves as a Commissioner on the Medicaid and CHIP Payment and Access Commission, which advises Congress on federal Medicaid and CHIP policy.
Recent Posts by Sara Rosenbaum
Medicaid reform demands a deliberative process, one that operates in regular order and carefully considers a wide range of options for controlling costs in the nation’s single largest source of health insurance.
The Israeli system rests on the concept of competing private health plans selling care in a market of empowered consumers. But one crucial difference is how Israel approaches the question of what it means to be covered.
Titled “Flexible Block Grant Option for States,” the amendment adds a coda of sorts to the bill’s new Medicaid per capita cap payment system. It would virtually eliminate any coverage obligations.
Anyone who has had the chance to witness (or be part of) any of the epic health reform dramas that continually play out in Washington D.C. will agree: in the end, it always comes down to Medicaid. We have once again arrived at one of those moments.
For more than three and a half decades health care expenditures in the United States have grown at a much higher rate than those in other wealthy nations. To get a handle on prices, policymakers should seriously consider rate regulation.
The AHCA radically restructures Medicaid’s federal financing system. Along with its withdrawal of the ACA’s adult eligibility funding enhancement, the bill would shift an estimated $370 billion in financial risks to the states over the coming decade.
March 10, 2017 | Medicaid and CHIP
Despite the health benefits and cost savings that flow from family planning, there can be little doubt that withdrawal of federal funding from excluded providers will adversely affect access to care.
The Trump Administration could take steps---under existing legislative authority---to broaden the longstanding definition of “community benefit” spending to promote fuller community-wide health improvement partnerships between tax-exempt hospitals and the communities they serve.
The Supreme Court's 5-3 majority ruling overturning two restrictions on abortion in Texas represents a full-throated reaffirmation of the balancing test first set forth by the Court 25 years ago in Planned Parenthood of Southeastern United States v. Casey.
On April 25, CMS released a behemoth 1,425-page final rule that will guide the delivery of health care for tens of millions of children and adults. This posts provides an overview of what the rule seeks to accomplish and how it tries to position health care delivery under a regulatory system...